Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 797280, 8 pages
http://dx.doi.org/10.1155/2015/797280
Research Article

The Kampo Medicine Yokukansan Decreases MicroRNA-18 Expression and Recovers Glucocorticoid Receptors Protein Expression in the Hypothalamus of Stressed Mice

1Division of Molecular Brain Science, Research Institute of Traditional Asian Medicine, Kinki University, Osaka-sayama, Osaka 589-8511, Japan
2Division of Women Medicine, Research Institute of Traditional Asian Medicine, Kinki University, Osaka-sayama, Osaka 589-8511, Japan
3Osaka Prefectural Hospital Organization, Osaka 558-8558, Japan

Received 5 December 2014; Accepted 2 April 2015

Academic Editor: Yu-Ping Tang

Copyright © 2015 Shoko Shimizu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Bartanusz, D. Jezova, L. T. Bertini, F. J. H. Tilders, J.-M. Aubry, and J. Z. Kiss, “Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotrophic paraventricular neurons,” Endocrinology, vol. 132, no. 2, pp. 895–902, 1993. View at Google Scholar · View at Scopus
  2. K. S. Kendler, L. M. Karkowski, and C. A. Prescott, “Causal relationship between stressful life events and the onset of major depression,” American Journal of Psychiatry, vol. 156, no. 6, pp. 837–841, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Aguilera and C. Rabadan-Diehl, “Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation,” Regulatory Peptides, vol. 96, no. 1-2, pp. 23–29, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. P. W. Gold and D. S. Charney, “Diseases of the mind and brain: depression: a disease of the mind, brain, and body.,” American Journal of Psychiatry, vol. 159, no. 11, p. 1826, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. B. S. McEwen, “Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders,” Annals of the New York Academy of Sciences, vol. 1032, pp. 1–7, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. J. P. Herman, P. D. Patel, H. Akil, and S. J. Watson, “Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat,” Molecular Endocrinology, vol. 3, no. 11, pp. 1886–1894, 1989. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Zhe, H. Fang, and S. Yuxiu, “Expressions of hippocampal mineralocorticoid receptor (MR) and glucocorticoid receptor (GR) in the single-prolonged stress-rats,” Acta Histochemica et Cytochemica, vol. 41, no. 4, pp. 89–95, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Thomson and M. Craighead, “Innovative approaches for the treatment of depression: targeting the HPA axis,” Neurochemical Research, vol. 33, no. 4, pp. 691–707, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. C. M. Pariante and S. L. Lightman, “The HPA axis in major depression: classical theories and new developments,” Trends in Neurosciences, vol. 31, no. 9, pp. 464–468, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. E. R. De Kloet, M. Joëls, and F. Holsboer, “Stress and the brain: from adaptation to disease,” Nature Reviews Neuroscience, vol. 6, no. 6, pp. 463–475, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. P. Boyle, J. A. Brewer, M. Funatsu et al., “Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 2, pp. 473–478, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. E. R. De Kloet and J. M. H. M. Reul, “Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems,” Psychoneuroendocrinology, vol. 12, no. 2, pp. 83–105, 1987. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. H. M. Reul and E. R. De Kloet, “Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation,” Endocrinology, vol. 117, no. 6, pp. 2505–2511, 1985. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Myers, J. M. McKlveen, and J. P. Herman, “Glucocorticoid actions on synapses, circuits, and behavior: implications for the energetics of stress,” Frontiers in Neuroendocrinology, vol. 35, no. 2, pp. 180–196, 2014. View at Publisher · View at Google Scholar
  15. T. Hiratsuka, S. Matsuzaki, S. Miyata et al., “Yokukansan inhibits neuronal death during ER stress by regulating the unfolded protein response,” PLoS ONE, vol. 5, no. 10, Article ID e13280, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. R. W. Carthew, “Gene regulation by microRNAs,” Current Opinion in Genetics & Development, vol. 16, no. 2, pp. 203–208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Wang, H. M. Stricker, D. Gou, and L. Liu, “MicroRNA: past and present,” Frontiers in Bioscience, vol. 12, no. 6, pp. 2316–2329, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. X. Cao, G. Yeo, A. R. Muotri, T. Kuwabara, and F. H. Gage, “Noncoding RNAs in the mammalian central nervous system,” Annual Review of Neuroscience, vol. 29, pp. 77–103, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Dalmay, “MicroRNAs and cancer,” Journal of Internal Medicine, vol. 263, no. 4, pp. 366–375, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Stefani and F. J. Slack, “Small non-coding RNAs in animal development,” Nature Reviews Molecular Cell Biology, vol. 9, no. 3, pp. 219–230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Chiu, A. Alqadah, and C. Chang, “The role of microRNAs in regulating neuronal connectivity,” Frontiers in Cellular Neuroscience, vol. 7, article 283, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Vreugdenhil, C. S. L. Verissimo, R. Mariman et al., “MicroRNA 18 and 124a down-regulate the glucocorticoid receptor: implications for glucocorticoid responsiveness in the brain,” Endocrinology, vol. 150, no. 5, pp. 2220–2228, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Miyata, Y. Koyama, K. Takemoto et al., “Plasma corticosterone activates SGK1 and induces morphological changes in oligodendrocytes in corpus callosum,” PLoS ONE, vol. 6, no. 5, Article ID e19859, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Kanno, Z. Kawakami, K. Mizoguchi, Y. Ikarashi, Y. Kase, and H. Ariga, “Yokukansan, a kampo medicine, protects PC12 cells from glutamate-induced death by augmenting gene expression of cystine/glutamate antiporter system Xc-,” PLoS ONE, vol. 9, no. 12, Article ID e116275, 2014. View at Publisher · View at Google Scholar
  25. T. Ishikawa, S. Miyata, Y. Koyama et al., “Transient expression of Xpn, an XLMR protein related to neurite extension, during brain development and participation in neurite outgrowth,” Neuroscience, vol. 214, pp. 181–191, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. M. N. Silverman and E. M. Sternberg, “Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction,” Annals of the New York Academy of Sciences, vol. 1261, no. 1, pp. 55–63, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Imamura, M. Tabuchi, H. Kushida et al., “The blood-brain barrier permeability of geissoschizine methyl ether in Uncaria hook, a galenical constituent of the traditional Japanese medicine yokukansan,” Cellular and Molecular Neurobiology, vol. 31, no. 5, pp. 787–793, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Nishi, T. Yamaguchi, K. Sekiguchi et al., “Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin1A receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan,” Neuroscience, vol. 207, pp. 124–136, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Tabuchi, S. Imamura, Z. Kawakami, Y. Ikarashi, and Y. Kase, “The blood-brain barrier permeability of 18β-glycyrrhetinic acid, a major metabolite of glycyrrhizin in Glycyrrhiza root, a constituent of the traditional Japanese medicine yokukansan,” Cellular and Molecular Neurobiology, vol. 32, no. 7, pp. 1139–1146, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Kushida, M. Fukutake, M. Tabuchi et al., “Simultaneous quantitative analyses of indole and oxindole alkaloids of Uncaria Hook in rat plasma and brain after oral administration of the traditional Japanese medicine Yokukansan using high-performance liquid chromatography with tandem mass spectrometry,” Biomedical Chromatography, vol. 27, no. 12, pp. 1647–1656, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Liposits, R. M. Uht, R. W. Harrison, F. P. Gibbs, W. K. Paull, and M. C. Bohn, “Ultrastructural localization of glucocorticoid receptor (GR) in hypothalamic paraventricular neurons synthesizing corticotropin releasing factor (CRF),” Histochemistry, vol. 87, no. 5, pp. 407–412, 1987. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Laflamme, N. Barden, and S. Rivest, “Corticotropin-releasing factor and glucocorticoid receptor (GR) gene expression in the paraventricular nucleus of immune-challenged transgenic mice expressing type II GR antisense ribonucleic acid,” Journal of Molecular Neuroscience, vol. 8, no. 3, pp. 165–179, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Matsuda, T. Kishi, H. Shibayama, and N. Iwata, “Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta-analysis of randomized controlled trials,” Human Psychopharmacology, vol. 28, no. 1, pp. 80–86, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Matsumoto, Q. Zhao, Y. Niu et al., “Kampo formulations, chotosan, and yokukansan, for dementia therapy: existing clinical and preclinical evidence,” Journal of Pharmacological Sciences, vol. 122, no. 4, pp. 257–269, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Kumar and E. B. Thompson, “Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions,” Molecular Endocrinology, vol. 17, no. 1, pp. 1–10, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. R. H. DeRijk, M. J. Schaaf, F. J. Stam et al., “Very low levels of the glucocorticoid receptor β isoform in the human hippocampus as shown by Taqman RT-PCR and immunocytochemistry,” Molecular Brain Research, vol. 116, no. 1-2, pp. 17–26, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. M. J. M. Schaaf and J. A. Cidlowski, “Molecular mechanisms of glucocorticoid action and resistance,” Journal of Steroid Biochemistry and Molecular Biology, vol. 83, no. 1–5, pp. 37–48, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. R. H. Derijk, M. J. M. Schaaf, G. Turner et al., “A human glucocorticoid receptor gene variant that increases the stability of the glucocorticoid receptor β-isoform mRNA is associated with rheumatoid arthritis,” Journal of Rheumatology, vol. 28, no. 11, pp. 2383–2388, 2001. View at Google Scholar · View at Scopus
  39. N. Z. Lu and J. A. Cidlowski, “Glucocorticoid receptor isoforms generate transcription specificity,” Trends in Cell Biology, vol. 16, no. 6, pp. 301–307, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Uchida, A. Nishida, K. Hara et al., “Characterization of the vulnerability to repeated stress in Fischer 344 rats: possible involvement of microRNA-mediated down-regulation of the glucocorticoid receptor,” European Journal of Neuroscience, vol. 27, no. 9, pp. 2250–2261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. R. V. Durairaj and E. R. Koilmani, “Environmental enrichment modulates glucocorticoid receptor expression and reduces anxiety in Indian field male mouse Mus booduga through up-regulation of microRNA-124a,” General and Comparative Endocrinology, vol. 199, pp. 26–32, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. A. J. Dunn, “Cytokine activation of the HPA axis,” Annals of the New York Academy of Sciences, vol. 917, pp. 608–617, 2000. View at Google Scholar · View at Scopus
  43. M. Hamon and P. Blier, “Monoamine neurocircuitry in depression and strategies for new treatments,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 45, pp. 54–63, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Terawaki, Y. Ikarashi, K. Sekiguchi, Y. Nakai, and Y. Kase, “Partial agonistic effect of yokukansan on human recombinant serotonin 1A receptors expressed in the membranes of Chinese hamster ovary cells,” Journal of Ethnopharmacology, vol. 127, no. 2, pp. 306–312, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. N. Egashira, K. Iwasaki, A. Ishibashi et al., “Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex,” Progress in Neuro-Psychopharmacology & Biological Psychiatry, vol. 32, no. 6, pp. 1516–1520, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. H. Kanno, K. Sekiguchi, T. Yamaguchi et al., “Effect of yokukansan, a traditional Japanese medicine, on social and aggressive behaviour of para-chloroamphetamine-injected rats,” Journal of Pharmacy and Pharmacology, vol. 61, no. 9, pp. 1249–1256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Ueda, S. Ugawa, Y. Ishida, and S. Shimada, “Geissoschizine methyl ether has third-generation antipsychotic-like actions at the dopamine and serotonin receptors,” European Journal of Pharmacology, vol. 671, no. 1-3, pp. 79–86, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. N. P. Maric and M. Adzic, “Pharmacological modulation of HPA axis in depression—new avenues for potential therapeutic benefits,” Psychiatria Danubina, vol. 25, no. 3, pp. 299–305, 2013. View at Google Scholar · View at Scopus